| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
197,143 |
176,811 |
$67.65M |
| 0510 |
|
148,998 |
138,274 |
$12.13M |
| 00003 |
Internal/system code - not a standard HCPCS code |
3,962 |
3,344 |
$1.70M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
2,388 |
2,212 |
$459K |
| 0002A |
|
6,847 |
5,909 |
$193K |
| 0001A |
|
7,013 |
5,987 |
$193K |
| 90837 |
Psychotherapy, 53 minutes with patient |
3,449 |
815 |
$88K |
| 0054A |
|
1,776 |
1,773 |
$72K |
| 0004A |
|
1,901 |
1,900 |
$71K |
| 99078 |
|
1,812 |
688 |
$70K |
| 0011A |
|
1,973 |
1,528 |
$60K |
| 0124A |
|
1,299 |
1,262 |
$56K |
| 0012A |
|
1,805 |
1,490 |
$55K |
| 0071A |
|
1,438 |
1,420 |
$50K |
| 0064A |
|
1,139 |
1,139 |
$45K |
| 91322 |
|
210 |
207 |
$25K |
| 0031A |
|
552 |
529 |
$21K |
| 0134A |
|
274 |
274 |
$12K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,674 |
4,307 |
$11K |
| 90832 |
Psychotherapy, 30 minutes with patient |
430 |
134 |
$10K |
| 90480 |
|
296 |
291 |
$9K |
| 0052A |
|
229 |
229 |
$9K |
| 0072A |
|
191 |
191 |
$8K |
| 0051A |
|
160 |
160 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
123,242 |
77,115 |
$6K |
| 0003A |
|
146 |
144 |
$5K |
| 0074A |
|
76 |
76 |
$5K |
| 0081A |
|
56 |
56 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19,942 |
17,556 |
$3K |
| 0154A |
|
46 |
46 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
54 |
12 |
$2K |
| Z7500 |
|
97,041 |
90,648 |
$2K |
| 0082A |
|
30 |
30 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
58 |
29 |
$2K |
| 0111A |
|
19 |
19 |
$1K |
| 0013A |
|
36 |
36 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,595 |
2,252 |
$1K |
| 0112A |
|
13 |
13 |
$871.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
19,543 |
17,212 |
$709.01 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41,193 |
26,779 |
$612.28 |
| 36415 |
Collection of venous blood by venipuncture |
29,693 |
26,933 |
$294.70 |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,834 |
2,670 |
$228.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15,629 |
13,486 |
$192.00 |
| 85027 |
|
5,990 |
5,059 |
$167.00 |
| 80061 |
Lipid panel |
3,269 |
3,192 |
$124.20 |
| Q3014 |
Telehealth originating site facility fee |
71,362 |
37,129 |
$121.14 |
| 99205 |
Prolong outpt/office vis |
4,291 |
1,814 |
$121.03 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
873 |
816 |
$18.60 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,439 |
4,503 |
$17.85 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
34,487 |
25,618 |
$12.00 |
| 84460 |
|
1,510 |
1,481 |
$0.00 |
| 84466 |
|
606 |
557 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
53,978 |
28,604 |
$0.00 |
| 83721 |
|
2,224 |
2,091 |
$0.00 |
| 97810 |
|
2,656 |
588 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
339 |
258 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
570 |
318 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,647 |
5,745 |
$0.00 |
| 90633 |
|
3,317 |
1,297 |
$0.00 |
| Z6500 |
|
67 |
66 |
$0.00 |
| 90658 |
|
574 |
454 |
$0.00 |
| 81002 |
|
4,430 |
2,184 |
$0.00 |
| 82465 |
|
545 |
491 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,762 |
1,838 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,235 |
4,204 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,581 |
1,652 |
$0.00 |
| 90715 |
|
2,558 |
1,355 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
31 |
18 |
$0.00 |
| 90670 |
|
3,178 |
1,457 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,284 |
1,738 |
$0.00 |
| 83540 |
|
658 |
604 |
$0.00 |
| 90750 |
|
1,744 |
1,318 |
$0.00 |
| 83718 |
|
572 |
516 |
$0.00 |
| 90649 |
|
2,721 |
1,703 |
$0.00 |
| 82947 |
|
1,130 |
1,107 |
$0.00 |
| 99173 |
|
363 |
186 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,359 |
5,738 |
$0.00 |
| 80076 |
|
174 |
174 |
$0.00 |
| 86900 |
|
411 |
316 |
$0.00 |
| 99188 |
|
2,038 |
1,210 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
929 |
657 |
$0.00 |
| 83655 |
|
836 |
835 |
$0.00 |
| 86787 |
|
117 |
85 |
$0.00 |
| Z6202 |
|
132 |
132 |
$0.00 |
| Z6304 |
|
504 |
359 |
$0.00 |
| 59425 |
|
569 |
374 |
$0.00 |
| 84450 |
|
543 |
536 |
$0.00 |
| 90700 |
|
155 |
110 |
$0.00 |
| 81003 |
|
50 |
42 |
$0.00 |
| 86480 |
|
215 |
200 |
$0.00 |
| 90671 |
|
401 |
267 |
$0.00 |
| 82565 |
|
51 |
51 |
$0.00 |
| 90662 |
|
143 |
129 |
$0.00 |
| 84439 |
|
95 |
84 |
$0.00 |
| Z6300 |
|
86 |
81 |
$0.00 |
| Z6400 |
|
277 |
275 |
$0.00 |
| 0272 |
|
160 |
160 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
35 |
26 |
$0.00 |
| 84520 |
|
49 |
49 |
$0.00 |
| 82570 |
|
171 |
151 |
$0.00 |
| 90707 |
|
99 |
39 |
$0.00 |
| 83020 |
|
13 |
13 |
$0.00 |
| 90734 |
|
86 |
84 |
$0.00 |
| 87338 |
|
97 |
97 |
$0.00 |
| Z6302 |
|
27 |
27 |
$0.00 |
| 86708 |
|
15 |
13 |
$0.00 |
| 90710 |
|
341 |
114 |
$0.00 |
| 85014 |
|
13 |
13 |
$0.00 |
| 90713 |
|
52 |
26 |
$0.00 |
| 90648 |
|
44 |
44 |
$0.00 |
| S4993 |
Contraceptive pills for birth control |
14 |
14 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
96 |
52 |
$0.00 |
| 82274 |
|
26 |
25 |
$0.00 |
| 86038 |
|
29 |
29 |
$0.00 |
| 83013 |
|
13 |
13 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
15 |
$0.00 |
| Z6308 |
|
14 |
12 |
$0.00 |
| 90686 |
|
28,540 |
13,375 |
$0.00 |
| 90677 |
|
2,004 |
1,309 |
$0.00 |
| J3490 |
Unclassified drugs |
3,809 |
3,572 |
$0.00 |
| Z1034 |
|
7,853 |
5,962 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,132 |
3,882 |
$0.00 |
| 90656 |
|
4,617 |
1,896 |
$0.00 |
| 87625 |
|
112 |
88 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
306 |
228 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
988 |
330 |
$0.00 |
| 90739 |
|
3,992 |
3,059 |
$0.00 |
| 88142 |
|
776 |
574 |
$0.00 |
| 86901 |
|
411 |
316 |
$0.00 |
| 82784 |
|
55 |
54 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,911 |
1,426 |
$0.00 |
| 0271 |
|
631 |
631 |
$0.00 |
| 90651 |
|
513 |
274 |
$0.00 |
| Z7610 |
|
2,062 |
1,913 |
$0.00 |
| D1310 |
|
809 |
615 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,122 |
1,058 |
$0.00 |
| 86592 |
|
162 |
101 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
982 |
814 |
$0.00 |
| Z1038 |
|
16 |
14 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,533 |
1,626 |
$0.00 |
| 86850 |
|
411 |
316 |
$0.00 |
| 90680 |
|
1,785 |
695 |
$0.00 |
| 85018 |
|
357 |
241 |
$0.00 |
| 90697 |
|
1,375 |
634 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
972 |
693 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
846 |
548 |
$0.00 |
| Z1032 |
|
458 |
409 |
$0.00 |
| 90647 |
|
802 |
454 |
$0.00 |
| 86803 |
|
470 |
465 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,049 |
854 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,847 |
2,641 |
$0.00 |
| 82607 |
|
666 |
619 |
$0.00 |
| 87081 |
|
569 |
318 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
545 |
523 |
$0.00 |
| 90619 |
|
827 |
500 |
$0.00 |
| 90716 |
|
271 |
131 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
318 |
248 |
$0.00 |
| V5008 |
Hearing screening |
375 |
193 |
$0.00 |
| 90696 |
|
240 |
74 |
$0.00 |
| 90674 |
|
94 |
87 |
$0.00 |
| 86481 |
|
66 |
66 |
$0.00 |
| 86762 |
|
136 |
98 |
$0.00 |
| 86141 |
|
60 |
54 |
$0.00 |
| 90723 |
|
440 |
211 |
$0.00 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
85 |
62 |
$0.00 |
| 87340 |
|
54 |
51 |
$0.00 |
| 88720 |
|
652 |
413 |
$0.00 |
| 82728 |
|
684 |
639 |
$0.00 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
241 |
138 |
$0.00 |
| 90688 |
|
425 |
380 |
$0.00 |
| Z6404 |
|
28 |
28 |
$0.00 |
| 85652 |
|
92 |
80 |
$0.00 |
| 86364 |
|
55 |
55 |
$0.00 |
| Z6406 |
|
152 |
152 |
$0.00 |
| 82043 |
|
129 |
114 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
166 |
113 |
$0.00 |
| Z6402 |
|
26 |
26 |
$0.00 |
| 82950 |
|
37 |
24 |
$0.00 |
| 0636 |
|
29 |
28 |
$0.00 |
| 90620 |
|
170 |
58 |
$0.00 |
| 84132 |
|
39 |
38 |
$0.00 |
| 86704 |
|
12 |
12 |
$0.00 |
| 99383 |
|
17 |
15 |
$0.00 |
| 86706 |
|
13 |
12 |
$0.00 |
| 90744 |
|
32 |
16 |
$0.00 |